Inmagene LLC
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis (NCT07037901) | Inmagene LLC | 2025-06-17 |
| Safety and Pharmacokinetics of Subcutaneous Dose of IMG-007 in Healthy Participants (NCT06304740) | Inmagene LLC | 2024-03-06 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants (NCT06060977) | Inmagene LLC | 2023-09-25 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) (NCT05984784) | Inmagene LLC | 2023-08-09 |
| Study to Evaluate IMG-004 in Healthy Participants (NCT05349097) | Inmagene LLC | 2022-08-08 |
| Evaluate IMG-007 in Healthy Participants (NCT05353972) | Inmagene LLC | 2022-07-05 |
| ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis (NCT04795141) | Inmagene LLC | 2021-08-24 |
Track Inmagene LLC automatically
Every clearance here is in the API, with alerts when new ones post.